Holen Sie sich die Stockscreener-App
50.25
0.03%
-0.02
Schlusskurs vom Vortag:
$50.27
Offen:
$50.15
24-Stunden-Volumen:
129.92K
Relative Volume:
0.14
Marktkapitalisierung:
$2.42B
Einnahmen:
$1.35B
Nettoeinkommen (Verlust:
$163.34M
KGV:
15.34
EPS:
3.2763
Netto-Cashflow:
$189.17M
1W Leistung:
-0.21%
1M Leistung:
-0.47%
6M Leistung:
-21.29%
1J Leistung:
-31.65%
1-Tages-Spanne:
$50.00
$50.60
1-Wochen-Bereich:
$48.98
$50.77
52-Wochen-Spanne:
$47.31
$94.98
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Branche
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
50.27 | 2.42B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
125.52 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.62 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
361.19 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.07 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.32 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | Bestätigt | Barrington Research | Outperform |
| 2025-08-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-06-26 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-02-07 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | Eingeleitet | CL King | Buy |
| 2024-09-11 | Eingeleitet | BofA Securities | Neutral |
| 2024-09-10 | Eingeleitet | BTIG Research | Buy |
| 2024-06-12 | Hochstufung | Needham | Hold → Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Earnings visualization tools for Haemonetics CorporationWeekly Stock Report & Smart Swing Trading Techniques - newser.com
Is Haemonetics Corporation stock dividend growth reliableRate Cut & Weekly Market Pulse Updates - newser.com
When is the best time to exit Haemonetics CorporationRate Hike & Precise Swing Trade Entry Alerts - newser.com
Published on: 2025-11-02 20:37:56 - newser.com
Can Haemonetics Corporation (HAZ) stock test all time highsJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
How Haemonetics Corporation stock benefits from digital adoptionJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Haemonetics (HAE) to Release Earnings on Thursday - MarketBeat
Using RSI to spot recovery in Haemonetics Corporation2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is Haemonetics Corporation (HAZ) stock prepared for digital transitionMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Will Haemonetics Corporation (HAZ) stock issue positive guidanceMarket Trend Report & Free Technical Confirmation Trade Alerts - newser.com
Is Haemonetics Corporation stock a defensive play in 2025Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
Haemonetics Corporation (HAE) Stock forecasts - Yahoo! Finance UK
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
How Recent Developments Are Shaping the Haemonetics Investment Story - Yahoo Finance
Using data filters to optimize entry into Haemonetics CorporationQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - newser.com
Can Haemonetics Corporation stock weather global recessionEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Using AI based signals to follow Haemonetics CorporationTrade Exit Report & Safe Entry Zone Identification - newser.com
Can Haemonetics Corporation stock outperform in 2025 bull marketEarnings Performance Report & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Will Haemonetics Corporation stock outperform value stocks2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
What the charts say about Haemonetics Corporation todayWeekly Trend Recap & Technical Confirmation Alerts - newser.com
Will Haemonetics Corporation (HAZ) stock sustain bullish trend into 2025Market Performance Recap & Consistent Profit Alerts - newser.com
Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Riverwater Partners LLC Sells 5,091 Shares of Haemonetics Corporation $HAE - MarketBeat
Does Haemonetics Corporation fit your quant trading modelJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com
Haemonetics (NYSE:HAE) Cut to Sell (D+) at Weiss Ratings - MarketBeat
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):